Science and Research Content

EBSCO Publishing and Isabel Healthcare in deal to provide integrated access to content in Isabel and DynaMed -

Electronic research databases provider EBSCO Publishing (EBSCO), US, has announced a new agreement with Isabel Healthcare. The deal allows direct linking between the Isabel diagnosis tool and the evidence-based point-of-care tool DynaMed, allowing mutual customers to link from one resource to the other. The agreement brings the evidence-based content from DynaMed into the diagnostic process and allows users easier access regardless of whether a search begins in Isabel or DynaMed.

Isabel Healthcare provides a web-based application called Isabel, the industry leading diagnosis decision support system designed to provide essential diagnosis and treatment information at the point of need. For a given set of signs and symptoms, Isabel presents the clinician with a list of likely diagnoses to consider, and each diagnosis is linked to knowledge to help with further investigation, potential testing and treatment. The Isabel system has been extensively validated and is currently being used by leading healthcare systems across North America improving efficiency in decision making.

DynaMed is a clinical reference tool created by physicians for physicians and other healthcare professionals for use at the point-of-care. With clinically-organised summaries for more than 3,200 topics, DynaMed provides the latest content and resources with validity, relevance and convenience, making DynaMed an indispensable resource for answering most clinical questions during practice.

Updated daily, DynaMed editors monitor the content of over 500 medical journals on a daily basis. Each article is evaluated for clinical relevance and scientific validity. The new evidence is then integrated with existing content, and overall conclusions are changed as appropriate, representing a synthesis of the best available evidence. Through this process of Systematic Literature Surveillance, the best available evidence determines the content of DynaMed.

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.

Click here to read the original press release.

STORY TOOLS

  • |
  • |

sponsor links

For banner adsĀ click here